AE Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$755K Buy
10,810
+1,129
+12% +$78.9K 0.01% 795
2025
Q1
$712K Buy
9,681
+285
+3% +$20.9K 0.01% 811
2024
Q4
$616K Buy
9,396
+1,044
+13% +$68.4K 0.01% 840
2024
Q3
$651K Buy
8,352
+692
+9% +$53.9K 0.01% 810
2024
Q2
$597K Sell
7,660
-109
-1% -$8.5K 0.01% 834
2024
Q1
$526K Sell
7,769
-22,100
-74% -$1.5M 0.01% 805
2023
Q4
$2M Buy
29,869
+11,671
+64% +$783K 0.01% 905
2023
Q3
$1.23M Sell
18,198
-996
-5% -$67.4K 0.01% 1012
2023
Q2
$1.37M Buy
19,194
+2,428
+14% +$174K 0.01% 964
2023
Q1
$1.16M Sell
16,766
-473
-3% -$32.8K 0.01% 986
2022
Q4
$1.17M Buy
17,239
+263
+2% +$17.8K 0.01% 923
2022
Q3
$931K Sell
16,976
-1,262
-7% -$69.2K 0.01% 969
2022
Q2
$1.21M Buy
18,238
+2,184
+14% +$144K 0.01% 826
2022
Q1
$1.07M Sell
16,054
-27,492
-63% -$1.82M 0.01% 899
2021
Q4
$2.54M Buy
43,546
+960
+2% +$55.9K 0.02% 622
2021
Q3
$2.56M Buy
42,586
+1,621
+4% +$97.4K 0.02% 569
2021
Q2
$2.45M Sell
40,965
-24,032
-37% -$1.44M 0.02% 568
2021
Q1
$3.23M Buy
64,997
+14,301
+28% +$711K 0.03% 429
2020
Q4
$2.53M Buy
50,696
+16,267
+47% +$813K 0.03% 431
2020
Q3
$1.89M Sell
34,429
-1,080
-3% -$59.2K 0.03% 439
2020
Q2
$1.88M Buy
35,509
+3,538
+11% +$187K 0.03% 432
2020
Q1
$1.43M Sell
31,971
-22,846
-42% -$1.02M 0.03% 389
2019
Q4
$2.73M Buy
54,817
+10,381
+23% +$518K 0.06% 278
2019
Q3
$1.98M Sell
44,436
-1,397
-3% -$62.3K 0.06% 275
2019
Q2
$1.89M Buy
45,833
+25,053
+121% +$1.03M 0.06% 257
2019
Q1
$840K Buy
20,780
+4,942
+31% +$200K 0.06% 232
2018
Q4
$602K Sell
15,838
-12,738
-45% -$484K 0.1% 217
2018
Q3
$1.13M Buy
28,576
+7,854
+38% +$311K 0.06% 201
2018
Q2
$728K Buy
20,722
+1,993
+11% +$70K 0.05% 212
2018
Q1
$655K Sell
18,729
-3,260
-15% -$114K 0.05% 222
2017
Q4
$763K Buy
21,989
+11
+0.1% +$382 0.07% 195
2017
Q3
$745K Sell
21,978
-670
-3% -$22.7K 0.07% 189
2017
Q2
$772K Buy
22,648
+2,048
+10% +$69.8K 0.09% 182
2017
Q1
$641K Buy
20,600
+11,021
+115% +$343K 0.12% 150
2016
Q4
$262K Buy
+9,579
New +$262K 0.11% 160